Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
11.86
1.00 (9.21%)
At close: Sep 26, 2025, 3:05 PM
Contineum Therapeutics Class A Common Stock Revenue
Contineum Therapeutics Class A Common Stock reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Contineum Therapeutics Class A Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
41
Market Cap
332.57M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 50M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |